by Usha Govindarajulu | May 26, 2021 | Biostatistics, Blog, Usha Govindarajulu
COVID-19 challenges of publishing statistically relevant studies COVID-19 is a tricky period in which to attempt to publish new studies. Criticism came from reviewers and those reading the articles whether or not one showed negative results or positive results from...
by Usha Govindarajulu | Mar 3, 2021 | Biostatistics, Blog, Epidemiology, New York, Professor, Usha Govindarajulu
As of right now, this is what we know about serious safety concerns raised about these COVID-19 vaccines: the mRNA vaccines, Pfizer© and Moderna©, the Johnson & Johnson©vaccine, and the Oxford/Astrazeneca© vaccine. These are the current vaccines with...
by Usha Govindarajulu | Feb 3, 2021 | Biostatistics, Blog, Epidemiology, New York, Professor, Usha Govindarajulu
Recently, two more vaccines are being reviewed in the news for their efficacy and usefulness in the fight against COVID-19. The producers are Johnson & Johnson and Novavax. The Johnson & Johnson or J&J has been discussed earlier than the other since it...
by Usha Govindarajulu | Jan 20, 2021 | Biostatistics, Blog, Epidemiology, New York, Professor, Usha Govindarajulu
As we continue to hear news of COVID-19 variants making their landfall and presence in the United States, the mass vaccination campaign continues. Meanwhile as cases continue to surge, hospitals are overflowing, and deaths have reached almost 400,000, vaccinations...
by Usha Govindarajulu | Jan 6, 2021 | Biostatistics, Blog, Epidemiology, New York, Professor, Usha Govindarajulu
In the last several weeks we have been hearing news that a new variant, B.I.I.7, of COVID-19, first detected in the United Kingdom is being detected in other countries as well, including the United States. The onset of this new variant is bad timing since the United...
by Usha Govindarajulu | Dec 23, 2020 | Biostatistics, Blog, Epidemiology, New York, Professor, Usha Govindarajulu
Recently, the Pfizer© vaccine for COVID-19 has come under scrutiny for components in their vaccine which could lead to severe reactions by recipients of the vaccine and therefore could lead to anaphylaxis. Allergies to these components, especially polyethylene glycol...
